The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

GeneDX Holdings reports Q4 earnings on February 18th. Find out why WGS stock is a strong play in the booming genetics testing ...

Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...

Data from the study showed that HEMGENIX continues to deliver sustained factor IX activity levels for up to four years post-treatment. The treatment also provides long-term bleed protection, ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

groninger, a German manufacturer of filling and closing machines for the pharmaceutical, consumer healthcare and cosmetics industries, is expanding its U.S. headquarters in Charlotte. groninger USA ...

Along with researchers in the Faculty of Health Sciences and the Faculty of Science, Western projects received a total of $17 ...

Philadelphians can take some comfort in knowing that, at least in the startup sphere, the City of Brotherly Love remains leagues ahead of Kansas City, particularly in its booming biotech scene that ...

New research suggests that electrical spinal cord stimulation could improve muscle function for patients who have spinal ...

CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...